Unternehmen Ibere Pharmaceuticals
Aktien
A3CPP8
KYG468431013
IBER
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Louis J. Vollmer
BRD | Director/Board Member | - | - |
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Elaine Jones
BRD | Director/Board Member | 69 | - |
Calvin Johnson
BRD | Director/Board Member | 57 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Henrietta Ukwu
BRD | Director/Board Member | 64 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 3 450 000 | 0 | 0 | 80,00 % |
Aktie B | 1 | 13 800 000 | 13 800 000 ( 100,00 %) | 0 |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+107.89% | 4.54 Mrd. | |
+1.89% | 1.01 Mrd. | |
+2.00% | 980 Mio. | |
-35.43% | 963 Mio. | |
+41.91% | 872 Mio. | |
+25.02% | 809 Mio. | |
+1.63% | 664 Mio. | |
+0.90% | 612 Mio. | |
-.--% | 600 Mio. |